Molecular Research of Alzheimer's Disease

The incidence and prevalence of Alzheimer's Disease are increasing worldwide due to aging and comorbidities. The classical neuropathogenetic model, which concentrates on brain amyloid plaque deposition, neurofibrillary tangles, and cholinergic system dysfunction, is being expanded and integrate...

Full description

Saved in:
Bibliographic Details
Other Authors: Falsetti, Lorenzo (Editor)
Format: Electronic Book Chapter
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_113972
005 20230911
003 oapen
006 m o d
007 cr|mn|---annan
008 20230911s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-8439-3 
020 |a 9783036584386 
020 |a 9783036584393 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-8439-3  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a MJN  |2 bicssc 
100 1 |a Falsetti, Lorenzo  |4 edt 
700 1 |a Falsetti, Lorenzo  |4 oth 
245 1 0 |a Molecular Research of Alzheimer's Disease 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (206 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The incidence and prevalence of Alzheimer's Disease are increasing worldwide due to aging and comorbidities. The classical neuropathogenetic model, which concentrates on brain amyloid plaque deposition, neurofibrillary tangles, and cholinergic system dysfunction, is being expanded and integrated with newer molecular models. Understanding the relationships between the classical pathogenetic pathways and newer hypotheses is imperative for guiding future research and developing effective drugs. The existence of newer molecular mechanisms such as risk factors, comorbidities like vascular diseases and diabetes mellitus, and neuroanatomical/neurofunctional alterations as blood-brain barrier breakdown and neurovascular unit dysfunction, offer potential targets to improve Alzheimer's Disease diagnosis and treatment. This reprint provides an overview of the pathophysiologic role of newer and older molecular mechanisms of Alzheimer's Disease, shedding light on new insights for the development of new therapeutic approaches. It also highlights newer candidate markers of disease onset and progression. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Neurology & clinical neurophysiology  |2 bicssc 
653 |a Alzheimer&rsquo 
653 |a s disease 
653 |a mild cognitive impairment 
653 |a type 3 diabetes mellitus 
653 |a MCI 
653 |a neurovascular unit 
653 |a neurovascular unit dysfunction 
653 |a blood&ndash 
653 |a brain barrier 
653 |a brain barrier disruption 
653 |a atherosclerosis 
653 |a biomarkers 
653 |a prognosis 
653 |a diagnosis 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/7816  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/113972  |7 0  |z DOAB: description of the publication